Coronary Stents Market Report and Forecast 2024-2032

Global Coronary Stents Market Outlook

The global coronary stents market size was valued at USD 9.8 billion in 2023, driven by continuous innovation in the domain across the globe. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 16 billion by 2032.

Coronary Stents: Introduction

Coronary stents are tiny, expandable tubes used to treat narrowed or blocked coronary arteries, the vessels that supply blood to the heart. Often made of metal mesh, they're inserted into the artery via a catheter during a procedure known as angioplasty. Once in place, the stent expands against the artery walls, holding the artery open and improving blood flow. This helps alleviate symptoms like chest pain and reduces the risk of heart attacks.

Key Trends in the Global Coronary Stents Market

Continuous innovation has led to the development of more sophisticated stents, such as bioresorbable vascular scaffolds and drug-eluting stents with improved polymers and drugs, aimed at reducing the risk of artery re-narrowing and promoting better patient outcomes.

Increasing incidences of lifestyle-related health conditions, such as diabetes, obesity, and hypertension, are leading to a higher prevalence of coronary artery diseases globally, driving the demand for coronary stents.

There's a growing preference for minimally invasive surgeries over open surgeries, as they offer benefits like shorter recovery times and reduced post-operative complications, influencing the adoption rate of stenting procedures.

The market is also closely regulated, with frequent product approvals, recalls, and safety monitoring, ensuring the safety and efficacy of stents used in procedures.

Developing countries are experiencing rapid growth in the coronary stents market due to improving healthcare infrastructures, increasing access to medical care, and growing awareness about coronary artery disease treatments.

There is a trend towards customization and personalization of stents, including efforts to match stent types and materials to individual patient needs and anatomies for better outcomes.

Global Coronary Stents Market Segmentation

Market Breakup by Type

• Bare Metal Stents
• Drug Eluting Stents
• Bioresorbable Vascular Scaffold

Market Breakup by End User

• Hospitals
• Eye Clinics

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Coronary Stents Market Overview

North America leads in the coronary stents market due to advanced healthcare infrastructure, a high prevalence of coronary artery diseases, and strong adoption of advanced medical technologies. The region sees continuous innovation and significant investments in research and development, contributing to the growth and introduction of newer, more sophisticated stent technologies.

Europe follows closely, with a well-established healthcare system and increasing demand for minimally invasive procedures. The region's market is driven by the aging population, high healthcare expenditure, and favorable reimbursement policies. European countries are also notable for their stringent regulatory standards, ensuring high-quality and safe medical devices.

The Asia-Pacific region is witnessing rapid growth in the coronary stents market, fueled by increasing healthcare awareness, rising incidence of cardiovascular diseases, and improving healthcare infrastructure. Countries like China and India are pivotal due to their large populations and growing middle-class, which demands better healthcare services. The market is also benefiting from government initiatives aimed at modernizing healthcare and making advanced treatments more accessible.

Global Coronary Stents Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbott
• Medtronic Plc
• Boston Scientific Corporation
• Terumo Corporation
• B Braun Melsungen AG
• Biotronik
• Stentys SA
• C. R. Bard, Inc.
• Metabiomics
• MicroPort Scientific Corporation

This product will be delivered within 5-7 business days.